Definium Therapeutics (DFTX) Common Equity (2020 - 2026)
Definium Therapeutics' Common Equity was $918.68 million in Q2 2026, up 395.5% from $185.4 million a year earlier and up 229.5% from the prior quarter.
Definium Therapeutics (DFTX) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Definium Therapeutics came in at $332.33 million, up 37.6% from FY2024.
- Common Equity shows a five-year compound annual growth rate of 34.4% (FY2020 to FY2025).
- In earlier years, Common Equity was $241.45 million in FY2024 (+209.0%), $78.13 million in FY2023 (-48.2%), $150.92 million in FY2022 (-0.5%) and $151.66 million in FY2021 (+99.9%).
- The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q4 2020.
- Compared with a year earlier, Common Equity has increased for three straight quarters, with growth averaging 99.5% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was Q2 2026 (growth of 395.5%); the worst was Q3 2025 (a decline of 50.2%).
- Per Business Quant data, DFTX's Common Equity in the three quarters before Q2 2026 was $278.85 million (Q1 2026), $332.33 million (Q4 2025) and $130.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Definium Therapeutics | 4.00 Bn | 4.00 Bn | - | 918.68 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 918.68 Mn |
| Mar 31, 2026 | 278.85 Mn |
| Dec 31, 2025 | 332.33 Mn |
| Sep 30, 2025 | 130.60 Mn |
| Jun 30, 2025 | 185.40 Mn |
| Mar 31, 2025 | 222.81 Mn |
| Dec 31, 2024 | 241.45 Mn |
| Sep 30, 2024 | 262.19 Mn |
| Jun 30, 2024 | 202.05 Mn |
| Mar 31, 2024 | 196.06 Mn |
| Dec 31, 2023 | 78.13 Mn |
| Sep 30, 2023 | 95.98 Mn |
| Jun 30, 2023 | 105.97 Mn |
| Mar 31, 2023 | 130.34 Mn |
| Dec 31, 2022 | 150.92 Mn |
| Sep 30, 2022 | 153.59 Mn |
| Jun 30, 2022 | 124.50 Mn |
| Mar 31, 2022 | 136.81 Mn |
| Dec 31, 2021 | 151.66 Mn |
| Sep 30, 2021 | 164.27 Mn |
Definium Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=DFTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();